GlaxoSmithKline Pharmaceuticals Limited
Web: gsk-india.com NSE: GLAXO BSE: 500660 SECTOR: Healthcare - Pharmaceuticals & Biotechnology
2300 18(1%)
Near 52W Low of 2218
Volume
2L as on 26, May
Open
3,190
High
2,280
Low
2,248
Close
2,282
VWAP
2,292
52 Week High
3,516
52 Week Low
2,218
Quality Score
00/00
Growth Score
00/00
Valuation Score
00/00
Momentum Score
00/00
Analyst Recommendations
BUY/SELL
|
|
Analyst Price Target
-
Market Cap (cr)
38,963
No. of Shares
P/E
61.06
P/B
24.39
Face Value
10
Div. Yield
-
Book Value (TTM)
-
CASH
-
DEBT
-
EPS (TTM)
-
ROE
39.94
ROCE
-
Profit Growth
-
Listing Date
15-Dec-00
Promoter Holding
75%
FII Holding
4.62%
DII Holding
7.68%
Price Chart
Price Performance
1 Week4%
1 Month8%
3 Months13%
6 Months8%
1 Year27%
YTD7%
Moving Average
5 Day SMA2,311
10 Day SMA2,360
20 Day SMA2,385
30 Day SMA2,404
50 Day SMA2,389
61 Day SMA2,419
80 Day SMA2,443
200 Day SMA2,551
PIVOT LEVEL
| Standard | Camarilla | Fibonacci | Woodie's | |
|---|---|---|---|---|
| Resistance 3 | 2,372 | 2,312 | 2,357 | 2,366 |
| Resistance 2 | 2,357 | 2,308 | 2,340 | 2,354 |
| Resistance 1 | 2,328 | 2,304 | 2,330 | 2,322 |
| Pivot Point | 2,313 | 2,300 | 2,313 | 2,310 |
| Support 1 | 2,284 | 2,296 | 2,296 | 2,278 |
| Support 2 | 2,269 | 2,292 | 2,286 | 2,266 |
| Support 3 | 2,240 | 2,288 | 2,269 | 2,234 |
Competitors/Peers
| # | Symbol | MCAP | LTP | 1W | 1M | 6M | 1Y | P/E | Ind PE | Debt/Eq | Div Yld % | NP Qtr Rs.Cr. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SUNPHARMA | 4,42,187 | 1843 | 2% | 14% | 2% | 9% | 39 | 0 | 0 | 0 | |
| 2 | DIVISLAB | 1,80,280 | 6791 | 2% | 6% | 4% | 1% | 65 | 0 | 0 | 0 | |
| 3 | TORNTPHARM | 1,53,281 | 4529 | 0% | 8% | 18% | 40% | 64 | 0 | 0 | 0 | |
| 4 | APOLLOHOSP | 1,19,047 | 8280 | 3% | 7% | 12% | 17% | 58 | 0 | 0 | 0 | |
| 5 | CIPLA | 1,14,869 | 1422 | 1% | 10% | 7% | 4% | 22 | 0 | 0 | 0 | |
| 6 | DRREDDY | 1,11,015 | 1330 | 0% | 1% | 7% | 7% | 20 | 0 | 0 | 0 | |
| 7 | ZYDUSLIFE | 1,09,378 | 1087 | 6% | 16% | 15% | 17% | 20 | 0 | 0 | 0 | |
| 8 | LUPIN | 1,04,017 | 2275 | 1% | 2% | 9% | 15% | 23 | 0 | 0 | 0 | |
| 9 | MANKIND | 1,00,482 | 2434 | 3% | 7% | 7% | 2% | 49 | 0 | 0 | 0 | |
| 10 | MAXHEALTH | 96,867 | 995 | 7% | 1% | 15% | 14% | 0 | 0 | 0 | 0 | |
| Load More | ||||||||||||
Quarterly Results
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 995 | 1041 | 980 | 805 | 974 | 949 | 1011 | 815 | 930 | 805 | 957 | 762 | 787 | 802 | 917 | 745 | 810 | 816 | 934 | 718 |
| Expenses | 644 | 670 | 644 | 554 | 641 | 658 | 689 | 584 | 673 | 587 | 668 | 618 | 618 | 574 | 660 | 596 | 634 | 618 | 678 | 586 |
| Operating Profit | 351 | 371 | 336 | 251 | 333 | 292 | 322 | 231 | 257 | 218 | 289 | 144 | 170 | 229 | 257 | 149 | 175 | 198 | 256 | 133 |
| OPM % | 35 | 36 | 34 | 31 | 34 | 31 | 32 | 28 | 28 | 27 | 30 | 19 | 22 | 29 | 28 | 20 | 22 | 24 | 27 | 18 |
| Other Income | 36 | 50 | 36 | 44 | 41 | 35 | 39 | 36 | 32 | -135 | 28 | 54 | 38 | 12 | 22 | 31 | 1322 | 4 | 30 | 46 |
| Interest | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 |
| Depreciation | 13 | 20 | 17 | 16 | 15 | 19 | 17 | 16 | 18 | 17 | 18 | 16 | 17 | 16 | 16 | 16 | 15 | 18 | 17 | 18 |
| Profit before tax | 373 | 400 | 354 | 279 | 359 | 308 | 344 | 249 | 271 | 65 | 299 | 181 | 190 | 224 | 262 | 163 | 1482 | 184 | 268 | 160 |
| Tax % | 26 | 26 | 27 | 27 | 27 | 25 | 27 | 27 | 28 | 30 | 27 | 27 | 30 | 27 | 26 | 27 | 18 | 18 | 24 | 24 |
| Net Profit | 278 | 296 | 257 | 205 | 263 | 230 | 252 | 182 | 194 | 46 | 218 | 132 | 133 | 165 | 193 | 119 | 1219 | 150 | 204 | 121 |
| EPS in Rs | 16.4 | 17.45 | 15.2 | 12.1 | 15.52 | 13.57 | 14.91 | 10.76 | 11.48 | 2.7 | 12.84 | 7.81 | 7.88 | 9.71 | 11.42 | 7.04 | 71.96 | 8.88 | 12.06 | 7.15 |
Profit and Loss
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Dec 2013 | Dec 2012 | Jan 1900 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3822 | 3749 | 3454 | 3252 | 3278 | 2926 | 3224 | 3128 | 2871 | 2908 | 2838 | 3305 | 2563 | 2647 | 3305 |
| Expenses | 2512 | 2570 | 2545 | 2447 | 2516 | 2327 | 2567 | 2527 | 2363 | 2489 | 2360 | 2672 | 2034 | 1824 | 2672 |
| Operating Profit | 1309 | 1179 | 909 | 804 | 762 | 598 | 657 | 601 | 508 | 420 | 478 | 633 | 528 | 822 | 633 |
| OPM % | 34 | 31 | 26 | 25 | 23 | 20 | 20 | 19 | 18 | 14 | 17 | 19 | 21 | 31 | 19 |
| Other Income | 166 | 149 | -21 | 103 | 1401 | 9 | -262 | 131 | 70 | 119 | 125 | 149 | 203 | 30 | 149 |
| Interest | 3 | 1 | 2 | 2 | 2 | 4 | 6 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 66 | 67 | 70 | 66 | 68 | 79 | 83 | 49 | 38 | 27 | 25 | 25 | 20 | 18 | 25 |
| Profit before tax | 1406 | 1260 | 816 | 839 | 2093 | 525 | 306 | 683 | 540 | 511 | 578 | 756 | 711 | 834 | 756 |
| Tax % | 26 | 26 | 28 | 27 | 19 | 32 | 70 | 35 | 35 | 34 | 35 | 37 | 32 | 33 | 37 |
| Net Profit | 1036 | 928 | 590 | 611 | 1695 | 358 | 93 | 445 | 351 | 337 | 376 | 476 | 482 | 562 | 476 |
| EPS in Rs | 61.15 | 54.75 | 34.83 | 36.05 | 100.04 | 21.14 | 5.5 | 26.29 | 20.7 | 19.88 | 22.2 | 28.12 | 28.43 | 33.17 | 28.12 |
| Dividend Payout % | 93 | 99 | 92 | 89 | 90 | 142 | 727 | 76 | 85 | 75 | 113 | 111 | 88 | 75 | 111 |
Cash Flows
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 903 | 1290 | 582 | 484 | 811 | 578 | 490 | 409 | 473 | 234 | 139 | 338 | 281 | 314 |
| Cash from Investing Activity | 397 | -46 | 9 | 808 | -406 | 418 | -57 | -153 | -104 | 301 | 499 | 180 | 189 | -110 |
| Cash from Financing Activity | -737 | -769 | -562 | -1543 | -524 | -696 | -428 | -358 | -307 | -511 | -638 | -497 | -494 | -441 |
| Net Cash Flow | 563 | 475 | 29 | -251 | -119 | 300 | 6 | -102 | 62 | 24 | 0 | 21 | -24 | -237 |
Balance Sheet
| Mar 2026 | Sep 2025 | Mar 2025 | Sep 2024 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 169 | 169 | 169 | 169 | 169 | 169 | 169 | 169 | 169 | 169 | 85 | 85 | 85 | 85 | 85 | 85 |
| Reserves | 2098 | 1538 | 1782 | 1503 | 1608 | 1572 | 2494 | 1309 | 1651 | 1970 | 1973 | 1922 | 2099 | 1744 | 1905 | 1922 |
| Borrowings | 33 | 36 | 10 | 15 | 19 | 16 | 20 | 35 | 0 | 1 | 1 | 2 | 2 | 3 | 4 | 5 |
| Other Liabilities | 2023 | 1922 | 2147 | 2059 | 1760 | 1570 | 1950 | 1602 | 1315 | 1771 | 1889 | 995 | 869 | 1384 | 1136 | 1077 |
| Total Liabilities | 4324 | 3665 | 4108 | 3746 | 3557 | 3327 | 4633 | 3115 | 3136 | 3911 | 3947 | 3004 | 3055 | 3216 | 3130 | 3088 |
| Fixed Assets | 281 | 291 | 284 | 296 | 321 | 330 | 331 | 387 | 758 | 432 | 325 | 258 | 204 | 123 | 100 | 89 |
| CWIP | 33 | 17 | 14 | 21 | 14 | 20 | 30 | 13 | 120 | 1003 | 923 | 605 | 268 | 115 | 62 | 44 |
| Investments | 1392 | 1313 | 1118 | 1001 | 813 | 518 | 366 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 10 | 55 |
| Other Assets | 2618 | 2044 | 2692 | 2428 | 2408 | 2458 | 3907 | 2715 | 2257 | 2477 | 2700 | 2140 | 2577 | 2977 | 2958 | 2900 |
| Total Assets | 4324 | 3665 | 4108 | 3746 | 3557 | 3327 | 4633 | 3115 | 3136 | 3911 | 3947 | 3004 | 3055 | 3216 | 3130 | 3088 |
Delivery
| # | Date | 2218 14% 2530 Value (Cr) | Q/T | 8 Del | 54 Del | 17 1 | 27-May | 2296 | 41 | 13 | 63 | 26 | 2 | 26-May | 2282 | 36 | 11 | 62 | 22 | 3 | 25-May | 2300 | 26 | 10 | 62 | 16 | 4 | 22-May | 2307 | 43 | 12 | 73 | 31 | 5 | 21-May | 2321 | 25 | 9 | 65 | 16 | 6 | 20-May | 2347 | 19 | 8 | 63 | 12 | 7 | 19-May | 2389 | 18 | 8 | 57 | 11 | 8 | 18-May | 2390 | 17 | 6 | 60 | 10 | 9 | 15-May | 2439 | 11 | 6 | 52 | 6 | 10 | 14-May | 2417 | 14 | 5 | 48 | 7 | 11 | 13-May | 2412 | 34 | 9 | 32 | 11 | 12 | 12-May | 2449 | 21 | 7 | 46 | 10 | 13 | 11-May | 2436 | 8 | 5 | 50 | 4 | 14 | 8-May | 2477 | 17 | 9 | 58 | 10 | 15 | 7-May | 2481 | 32 | 9 | 62 | 20 | 16 | 6-May | 2423 | 17 | 7 | 51 | 9 | 17 | 5-May | 2364 | 25 | 13 | 66 | 16 | 18 | 4-May | 2350 | 27 | 10 | 66 | 18 | 19 | 30-Apr | 2336 | 27 | 7 | 63 | 17 | 20 | 29-Apr | 2367 | 39 | 10 | 68 | 26 | 21 | 28-Apr | 2410 | 13 | 10 | 76 | 10 | 22 | 27-Apr | 2439 | 30 | 8 | 64 | 19 | 23 | 24-Apr | 2472 | 14 | 6 | 58 | 8 | 24 | 23-Apr | 2495 | 17 | 5 | 48 | 8 | 25 | 22-Apr | 2466 | 14 | 5 | 50 | 7 | 26 | 21-Apr | 2427 | 5 | 4 | 55 | 3 | 27 | 20-Apr | 2430 | 9 | 4 | 49 | 4 | 28 | 17-Apr | 2454 | 10 | 7 | 55 | 6 | 29 | 16-Apr | 2420 | 8 | 5 | 50 | 4 | 30 | 15-Apr | 2405 | 15 | 7 | 56 | 8 | 31 | 13-Apr | 2414 | 15 | 6 | 55 | 8 | 32 | 10-Apr | 2394 | 14 | 5 | 53 | 7 | 33 | 9-Apr | 2360 | 6 | 3 | 65 | 4 | 34 | 8-Apr | 2354 | 13 | 6 | 63 | 8 | 35 | 7-Apr | 2333 | 13 | 8 | 64 | 8 | 36 | 6-Apr | 2347 | 9 | 5 | 49 | 4 | 37 | 2-Apr | 2312 | 25 | 9 | 64 | 16 | 38 | 1-Apr | 2329 | 17 | 6 | 44 | 7 | 39 | 30-Mar | 2283 | 29 | 6 | 59 | 17 | 40 | 27-Mar | 2260 | 14 | 5 | 60 | 8 | 41 | 25-Mar | 2322 | 21 | 5 | 63 | 13 | 42 | 24-Mar | 2309 | 12 | 5 | 51 | 6 | 43 | 23-Mar | 2279 | 12 | 5 | 50 | 6 | 44 | 20-Mar | 2385 | 14 | 7 | 65 | 9 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Daily Market Cap
| Date | Total Market Cap | Change | Chg % |
|---|---|---|---|
| 28-May | 38,963c | 97c | 0.25 |
| 27-May | 39,060c | 115c | 0.30 |
| 26-May | 38,945c | 19c | 0.05 |
| 25-May | 38,963c | 391c | 0.99 |
| 22-May | 39,355c | 418c | 1.05 |
| 21-May | 39,773c | 3c | 0.01 |
| 20-May | 39,777c | 676c | 1.67 |
| 19-May | 40,453c | 29c | 0.07 |
| 18-May | 40,424c | 893c | 2.16 |
| 15-May | 41,316c | 439c | 1.07 |
| 14-May | 40,878c | 51c | 0.12 |
| 13-May | 40,827c | 734c | 1.76 |
| 12-May | 41,560c | 297c | 0.72 |
| 11-May | 41,264c | 783c | 1.86 |
| 07-May | 42,047c | 1,055c | 2.57 |
| 06-May | 40,991c | 1,011c | 2.53 |
| 05-May | 39,980c | 37c | 0.09 |
| 04-May | 40,017c | 468c | 1.18 |
| 30-Apr | 39,550c | 549c | 1.37 |
| 29-Apr | 40,098c | 762c | 1.87 |
| 28-Apr | 40,861c | 917c | 2.19 |
| 24-Apr | 41,777c | 76c | 0.18 |
| 23-Apr | 41,854c | 24c | 0.06 |
| 22-Apr | 41,877c | 732c | 1.78 |
| 21-Apr | 41,145c | 393c | 0.95 |
| 17-Apr | 41,538c | 762c | 1.87 |
| 15-Apr | 40,776c | 0 | 0 |
Stock Checklist
Price is below from 52 week high low average: 87%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: NO
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: NO
Promoters are buying the stock: NO